Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 10/20 | 0.91 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 7/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.56 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Ethylhexanoic Acid SCHEMBL15054 | 1.00 | CA2 (0.91) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL26121503 | 0.98 | CA2 (0.88) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL28932204 | 0.98 | CA2 (0.88) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL23174742 | 0.98 | CA2 (0.88) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL11414553 | 0.98 | CA2 (0.88) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL31140169 | 0.96 | CA2 (0.84) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL4579487 | 0.96 | CA2 (0.84) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL6313729 | 0.95 | CA2 (0.91) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL6130019 | 0.95 | CA2 (0.91) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL20582677 | 0.95 | CA2 (0.91) | CA2MAPK1CA1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8974627-B2 | Curable compositions containing silyl groups, and use thereof | EVONIK DEGUSSA GMBH (DE) | 2015-03-10 | — | — | US | disclosed |
| US-20120071564-A1 | Emulsions Based On Hydroxyl Compounds Bearing Silyl Groups | EVONIK GOLDSCHMIDT GMBH (DE) | 2012-03-22 | — | — | US | disclosed |
| US-20120067520-A1 | Curable Compositions Containing Silyl Groups, And Use Thereof | EVONIK GOLDSCHMIDT GMBH (DE) | 2012-03-22 | — | — | US | disclosed |
| US-20120028022-A1 | Modified alkoxylation products having at least one non-terminal alkoxysilyl group and used thereof in hardenable compounds with increased storage stability and extensibility | EVONIK GOLDSCHMIDT GMBH (DE) | 2012-02-02 | — | — | US | disclosed |
| US-20120029090-A1 | Modified alkoxylation products having at least one non-terminal alkoxysilyl group, with increased storage life and increased stretchability of the polymers prepared using them | EVONIK GOLDSCHMIDT GMBH (DE) | 2012-02-02 | — | — | US | disclosed |
| US-8067522-B2 | Low viscosity, alkoxysilane-functional prepolymers and a process for their preparation | BAYER MATERIALSCIENCE AG (DE) | 2011-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071564-A1 | Emulsions Based On Hydroxyl Compounds Bearing Silyl Groups | LIPA, EBP, CETP | CA2 4093/4885MAPK1 4522/4885CA1 3088/4885 |
| US-20120029090-A1 | Modified alkoxylation products having at least one non-terminal alkoxysilyl group, with increased storage life and increased stretchability of the polymers prepared using them | TELO2, ALKBH2, SMCHD1 | CA2 4084/4885MAPK1 3044/4885CA1 4629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.